We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | NYSE:LLY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 9.14 | 1.26% | 734.01 | 737.45 | 721.00 | 724.00 | 2,009,365 | 01:00:00 |
From Apr 2021 to Apr 2024
Innovent Biologics Inc. and Eli Lilly & Co. said the U.S. Food and Drug Administration is currently planning to hold an advisory committee meeting to discuss their biologics license application for sintilimab injection. "FDA Accepts Innovent, Eli Lilly Application for Sintilimab," published at 6:27 a.m. ET, incorrectly reported in the second paragraph that the agency isn't planning such a meeting.
(END) Dow Jones Newswires
May 18, 2021 09:47 ET (13:47 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Eli Lilly Chart |
1 Month Eli Lilly Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
